FDA Approves the Tecnis Symfony Intraocular Lens

FDA Approves the Tecnis Symfony Intraocular Lens

FDA Approves the Tecnis Symfony® Intraocular Lenses, the First and Only Extended Depth of Focus Lenses for People with Cataracts.

On July 15th, 2016 Abbot announced that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. In the communication released to the public, Eric D. Donnefled, M.D. of Ophthalmic Consultants of Long Island, New York and Thomas Frinzi, senior vice president of Abbott's vision business, weighed in on the impact this lens will have on the high-quality care surgeons can provide for their patients. 

"The Symfony intraocular lens is a new option I can offer my patients to improve their vision following cataract surgery, especially those who have difficulty focusing on objects at near distances because of presbyopia," said Dr. Donnefeld. "Many of my patients live very active lifestyles and want to see clearly at all distances, and without glasses if possible. With the Symfony lens, I can give patients the freedom to enjoy the activities that matter to them, while wearing glasses less."

"Abbott is focused on improving people's vision and their lives by helping them stay healthy and active. Symfony offers patients, including those with astimatism, and option for crisp, clear vision at all distances," said Frinzi. "This is an important addition to our portfolio of lenses, as we expect many patients to choose a Symfony lens over a standard monofocal lens, given its benefits. We are happy that we can offer more people around the world this new category of lenses." 

Read the press release in its entirety here.    Tecnis Symfony Press Release